Heparin Binding Protein as a Prognostic Biomarker of Sepsis Severity

Ain Shams University55 enrolled

Overview

the aim of the study is to correlate between the severity of sepsis and serum heparin binding protein in the patients admitted to ICU with sepsis., and detect its value as a prognostic biomarker in sepsis

Study Type

OBSERVATIONAL

Enrollment

Conditions

Sepsis HBP

Eligibility

Sex: ALLMin age: 20 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * adult whose age between 20 to70 years old * patients suffered from sepsis or septic shock (under the third international consensus definition of sepsis and septic shock) Exclusion Criteria: * Any pregnancy female * Any patient who is Neutropenic secondary to malignancy * Patients who is taking immunosuppressive therapy * Patients who is suffering fromHematological malignancy

Locations (1)

Omar Hamdy

Minya, Egypt

Outcomes

Primary Outcomes

Evaluate the level of Heparin binding protein in relation to patient clinical improvement measured by SOFA Score

Correlates the change of the level of Heparin binding protein in ng/ml to the clinical improvement of the patients which is measured by SOFA score

Time frame: 72 hours after meeting sepsis ceriteria

Secondary Outcomes

Heparin binding protein and mortality

Correlates the change of the level of Heparin binding protein in ng/ml And how can it is used to predict mortality

Time frame: 28 days after meeting sepsis ceriteria

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.